Idexx Laboratories (IDXX) Operating Expenses (2009 - 2026)

Idexx Laboratories (IDXX) has reported Operating Expenses for 18 consecutive years, with $360.2 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Operating Expenses rose 17.37% year-over-year to $360.2 million; the TTM figure through Mar 2026 stood at $1.4 billion (up 7.09% YoY), while the FY2025 annual figure was $1.3 billion, up 3.91% from the prior year.
• Operating Expenses came in at $360.2 million for Q1 2026 at Idexx Laboratories, up from $342.5 million in the prior quarter.
• The five-year high for Operating Expenses was $360.2 million in Q1 2026, with the low at $114.8 million in Q1 2023.
• Average Operating Expenses over 5 years is $236.4 million, with a median of $292.1 million recorded in 2024.
• Across the five-year window, Operating Expenses sank 33.48% in 2023 and soared 160.96% in 2024, its largest moves.
• Year by year, Operating Expenses stood at $126.5 million in 2022, then advanced by 9.78% to $138.8 million in 2023, then soared by 122.55% to $309.0 million in 2024, then climbed by 10.85% to $342.5 million in 2025, then grew by 5.15% to $360.2 million in 2026.
• According to Business Quant data, Operating Expenses over the past three periods registered $360.2 million, $342.5 million, and $328.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.